Search Header Logo

Diabetes Medication (from ADA 2020)

Authored by Chrismar Mocorro

Other, Specialty

Professional Development

Used 7+ times

Diabetes Medication (from ADA 2020)
AI

AI Actions

Add similar questions

Adjust reading levels

Convert to real-world scenario

Translate activity

More...

    Content View

    Student View

10 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Medication with high efficacy in decrease HBAIC are the following except?

Sitagliptin

Liraglutide

Pioglitazone

no exceptions

Answer explanation

SGLT2 inhibitors (empagliflozin, etc) and DPP-4 inhibitors ( Sitagliptin, etc) have only intermediate efficacy. Metformin, GLP-1 RAs (liraglutide), Thiazolidendiones (pioglitazone) and Sulfonylureas (gliclazide, glimeperidie) have high efficacy. Insulin has the highest efficacy

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What medications have high risks for hypoglycemia?

Sitagliptin

Pioglitazone

Liraglutide

all of the above

none of the above

Answer explanation

Only Sulfonylureas (2nd generation) and Insulin have high for developing hypoglycemia. The risk have no risk for developing hypoglycemia.

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What medication cause weight loss?

Sitagliptin

liraglutide

empagliflozin

all of the above

sitagliptin and empagliflozin

Answer explanation

weight loss - meftormin, sglt2 inhibitors, glp 1 RAs


neutral - DPP4 inhibitors


weight gain - thiazolidendiones, sulfonylureas, insulin


pneumonics for weight loss --


mag floz ka, ma loss imo ki-ki, empagliFLOZin, canagliFLOZin, dapagliFLOZin)


maglaba ka gamit TIDE, makaniwang jud na (liragluTIDE, lixisenaTIDE)

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which medication has a benefit or potential benefit for decreasing risk for ASCVD?

empagliflozin

metformin

liraglutide

pioglitazone

all of the above

Answer explanation

potential benefit: metformin and pioglitazone


benefit: empagliflozin, canagliflozin, GLP-1 RAs (meds ending with TIDE) except lixisenatide


ADA recommendations:

Among patients with type 2 diabetes who have established Atheroscleortic cardiovascular disease or indications of high risk established kidney disease, or heart failure, a SGLT-2 inhibitor or GLP 1 RA with demonstrated CVD benefit is recommended.

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What medication is contraindicated for heart failure?

dapagliflozin

pioglitazone

liraglutide

all of the above

none of the above

Answer explanation

pioglitaZONE- has increased risk for heart failure (tungod sa water retention, mao ng maka weight gain sad sya)

SAXAgliptin - potential risk for HF


empagliflozin, canagliflozin, and dapagliflozin - benefit for HF


pnemonics:


kung ma-friendZONE ka, makaheartbroken jud, ma heart failure ka, maSAXAktan ka talga

6.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which DPP4 inhibitors does not need renal dose adjustment?

linagliptin

sitagliptin

saxagliptin

all needs renal dose adjustment

all does not need renal dose adjustment

Answer explanation

pneumonics:


LINAgliptin - maLINAw na hindi kailangan ng Renal dose adjustment. mas maLINAw pa sa kulay ni LIto Lapid at NAncy binay.

7.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What medication has a risk for amputation ?

canagliflozin

liraglutide

sitagliptin

pioglitzone

Answer explanation

CANEagliflozin - na amputate mao ng CANE na sya

Access all questions and much more by creating a free account

Create resources

Host any resource

Get auto-graded reports

Google

Continue with Google

Email

Continue with Email

Classlink

Continue with Classlink

Clever

Continue with Clever

or continue with

Microsoft

Microsoft

Apple

Apple

Others

Others

Already have an account?